Additionally, survivors may have underlying cancer predisposition syndromes, resulting in secondary leukemia; specifically, survivors with an initial diagnosis of osteosarcoma followed by subsequent leukemia may be associated with an underlying p53 mutation. The gene discussed is TP53; the disease is osteosarcoma.